Swiftmerge Acquisition Corp. — Form 10-Q Summary
Filing identity: The supplied filing is for Swiftmerge Acquisition Corp., not Aleanna, Inc. It covers the quarter ended March 31, 2024; the financial statements are unaudited.
Business context and reporting period
Swiftmerge is a Cayman Islands blank-check company seeking an initial business combination. It had no operating business or operating revenue as of March 31, 2024. Shareholders approved an extension of the combination deadline to June 17, 2025. In February 2024, Swiftmerge and HDL Therapeutics mutually terminated their merger agreement; neither party owes the other a termination payment.
Financial results and position
| Metric | Q1 2024 / March 31, 2024 | Comparable period / prior year-end |
|---|---|---|
| Operating revenue | None | None |
| Formation and operating costs | $400,975 | $1,218,706 in Q1 2023 |
| Trust investment gain | $309,906 | $2,328,946 in Q1 2023 |
| Net income (loss) | $(91,069) | $1,110,240 in Q1 2023 |
| Cash outside Trust Account | $28,051 | $148,349 at December 31, 2023 |
| Trust Account investments | $13,360,262 | $24,376,178 at December 31, 2023 |
| Total liabilities | $3,450,951 | $3,170,274 at December 31, 2023 |
| Working capital deficit | $3,422,900 | — |
| Operating cash flow | $(120,298) | $(282,164) in Q1 2023 |
Q1 2024 loss per share was $0.01 for each reported share class, compared with reported income per share of $0.04 for redeemable Class A and Class B shares in Q1 2023. The filing reports no operating margins because the company has no operating revenue. The $11.3 million of trust withdrawals and matching redemption payments reflect shareholder redemptions, not operating cash generation.
The company had a $600,000 non-interest-bearing promissory note payable to its Sponsor, due at a business combination or liquidation, and $2,284 due to the Sponsor. No conventional long-term debt or off-balance-sheet arrangements were reported.
Material changes and management commentary
- At the March 2024 shareholder meeting, 1,031,997 Class A shares were redeemed for approximately $11.3 million, or about $10.92 per share. The Trust Account was approximately $13.4 million afterward.
- Non-redemption agreements provided for the Sponsor to assign investors an economic interest in Founder Shares in exchange for commitments not to redeem certain shares. The company recorded $326,773 as both a Sponsor contribution and finance cost.
- Management concluded that substantial doubt exists about the company’s ability to continue as a going concern for one year after issuance of the financial statements. Cash outside the Trust Account is not forecast to cover obligations through June 17, 2025. Management expects to pursue a business combination and may seek additional financing, but has no confirmed financing commitment and gives no assurance of success.
- Disclosure controls and procedures were reported as ineffective due to an unremediated material weakness involving recording an unbilled third-party service amount, timely removal of waived deferred underwriting fees, and interest income in preparation of 2022 financial statements. Management stated that additional analysis was performed and that the current-quarter financial statements fairly present the company’s position and results in all material respects. No material change in internal control occurred during the quarter.
- The filing reports no legal proceedings and no material changes to the risk factors disclosed in the 2023 Form 10-K. No business-combination guidance or forecast is provided.
Important facts for investors to verify
- Confirm the issuer identity: this filing is Swiftmerge Acquisition Corp., despite the request metadata naming Aleanna, Inc.
- Review the June 17, 2025 deadline, the remaining Trust Account balance, redemption terms, and any subsequent extensions or redemptions.
- Assess the going-concern warning, minimal unrestricted cash, Sponsor note, and absence of committed financing.
- Review the terminated HDL transaction and determine whether Swiftmerge has identified or agreed to a replacement target.
- Read the company’s disclosures and remediation plans concerning the material weakness and ineffective disclosure controls.